McKesson
MCK
#204
Rank
ยฃ78.16 B
Marketcap
ยฃ628.39
Share price
-0.43%
Change (1 day)
29.49%
Change (1 year)
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.

P/E ratio for McKesson (MCK)

P/E ratio as of January 2026 (TTM): 26.1

According to McKesson's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 26.0535. At the end of 2024 the company had a P/E ratio of 25.9.

P/E ratio history for McKesson from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202425.925.14%
202320.722.91%
202216.8-37.96%
202127.1-530.6%
2020-6.30-76.95%
2019-27.3-65.39%
2018-78.9-1324.12%
20176.45-57.96%
201615.3-28.81%
201521.5-16.56%
201425.8

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Cardinal Health
CAH
32.0 22.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AmerisourceBergen
ABC
21.7-16.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Henry Schein
HSIC
24.9-4.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Veradigm
MDRX
9.78-62.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerner
CERN
47.5 82.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Computer Programs and Systems
CPSI
27.8 6.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Owens & Minor
OMI
-0.1609-100.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Patterson Companies
PDCO
20.1-22.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
-105-501.74%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.